PGNY PROGYNY INC revenue, earnings and financials

For the quarter ended June 30, 2026, PROGYNY INC reported revenue of $351M (up 5.3% from a year earlier), net income of $28.1M and diluted EPS of $0.34; over the last four quarters revenue was $1.31B and net income $78.6M; for the fiscal year ended December 2025 revenue was $1.29B, up 10.4% on the year before.

PGNY annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.29B, gross profit $304M, operating income $85.3M, net income $58.5M (margin 4.5%), EPS $0.65
• Fiscal year ended Dec 2024: revenue $1.17B, gross profit $253M, operating income $67.5M, net income $54.3M (margin 4.7%), EPS $0.57
• Fiscal year ended Dec 2023: revenue $1.09B, gross profit $239M, operating income $62.2M, net income $62.0M (margin 5.7%), EPS $0.62
• Fiscal year ended Dec 2022: revenue $787M, gross profit $167M, operating income $23.3M, net income $30.4M (margin 3.9%), EPS $0.30
• Fiscal year ended Dec 2021: revenue $501M, gross profit $112M, operating income $32.3M, net income $65.8M (margin 13.1%), EPS $0.66

PGNY quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $351M (up 5.3% year over year), net income $28.1M, EPS $0.34
• Quarter ended Mar 31, 2026: revenue $329M (up 1.4% year over year), net income $24.2M, EPS $0.29
• Quarter ended Dec 31, 2025: revenue $318M (up 6.7% year over year), net income $12.5M, EPS $0.14
• Quarter ended Sep 30, 2025: revenue $313M (up 9.3% year over year), net income $13.9M, EPS $0.15
• Quarter ended Jun 30, 2025: revenue $333M (up 9.5% year over year), net income $17.1M, EPS $0.19
• Quarter ended Mar 31, 2025: revenue $324M (up 16.5% year over year), net income $15.1M, EPS $0.17
• Quarter ended Dec 31, 2024: revenue $298M (up 10.6% year over year), net income $10.5M, EPS $0.12
• Quarter ended Sep 30, 2024: revenue $287M (up 2.0% year over year), net income $10.4M, EPS $0.11
• Quarter ended Jun 30, 2024: revenue $304M (up 8.8% year over year), net income $16.5M, EPS $0.17
• Quarter ended Mar 31, 2024: revenue $278M (up 7.6% year over year), net income $16.9M, EPS $0.17
• Quarter ended Dec 31, 2023: revenue $270M (up 26.0% year over year), net income $13.5M, EPS $0.13
• Quarter ended Sep 30, 2023: revenue $281M (up 36.8% year over year), net income $15.9M, EPS $0.16
• Quarter ended Jun 30, 2023: revenue $279M (up 43.3% year over year), net income $15.0M, EPS $0.15
• Quarter ended Mar 31, 2023: revenue $258M (up 50.0% year over year), net income $17.7M, EPS $0.18
• Quarter ended Dec 31, 2022: revenue $214M (up 68.0% year over year), net income $3.41M, EPS $0.03
• Quarter ended Sep 30, 2022: revenue $205M (up 67.9% year over year), net income $13.2M, EPS $0.13
• Quarter ended Jun 30, 2022: revenue $195M (up 51.6% year over year), net income $8.77M, EPS $0.09
• Quarter ended Mar 31, 2022: revenue $172M (up 41.0% year over year), net income $4.97M, EPS $0.05
• Quarter ended Dec 31, 2021: revenue $128M, net income $15.1M, EPS $0.15
• Quarter ended Sep 30, 2021: revenue $122M, net income $16.8M, EPS $0.17

PGNY cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $210M, share buybacks $81.7M
• Fiscal year ended Dec 2024: operating cash flow $179M, share buybacks $300M
• Fiscal year ended Dec 2023: operating cash flow $189M, share buybacks $0
• Fiscal year ended Dec 2022: operating cash flow $80.4M, share buybacks $0
• Fiscal year ended Dec 2021: operating cash flow $26.0M, share buybacks n/a

PGNY balance sheet

• Jun 30, 2026: cash $153M, total assets $716M, total liabilities $263M, shareholders' equity $453M
• Mar 31, 2026: cash $132M, total assets $698M, total liabilities $259M, shareholders' equity $439M
• Dec 31, 2025: cash $112M, total assets $742M, total liabilities $226M, shareholders' equity $516M
• Sep 30, 2025: cash $134M, total assets $795M, total liabilities $235M, shareholders' equity $560M
• Jun 30, 2025: cash $133M, total assets $761M, total liabilities $246M, shareholders' equity $515M
• Mar 31, 2025: cash $109M, total assets $730M, total liabilities $263M, shareholders' equity $467M
• Dec 31, 2024: cash $162M, total assets $607M, total liabilities $185M, shareholders' equity $422M
• Sep 30, 2024: cash $91.5M, total assets $660M, total liabilities $225M, shareholders' equity $435M

What is PGNY's revenue?

PROGYNY INC reported $1.31B of revenue over its last four quarters, through June 30, 2026.

Is PGNY profitable?

Yes. PROGYNY INC earned $78.6M over the last four quarters.

What is PGNY's EPS?

Diluted earnings per share over the last four quarters were $0.92; $0.34 in the latest quarter.

PGNY ownership and insider trades · All stocks